Alamar Biosciences, Inc. (ALMR) Stock Statistics & Valuation Metrics

Alamar Biosciences, Inc. has a market cap or net worth of $2.27B. The enterprise value is $1.68K.

Alamar Biosciences, Inc. has 69,392,770 shares outstanding. The number of shares has decreased by -2.65% in one year.

Alamar Biosciences, Inc.’s return on equity (ROE) is 0.19 and return on invested capital (ROIC) is -26.47%.

The current PE Ratio of Alamar Biosciences, Inc. is ―. Alamar Biosciences, Inc.’s PEG ratio is 0.00.

In the last 12 months, Alamar Biosciences, Inc. had revenue of 74.21M and earned -29.82M in profits. Earnings per share was -0.45.

In the last 12 months, operating cash flow was -31.67M and capital expenditures -4.24M, giving a free cash flow of -35.91M billion.

Alamar Biosciences, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

Alamar Biosciences, Inc. upcoming earnings date is Aug 10, 2026, Before Open (Confirmed).

Alamar Biosciences, Inc. as a current ratio of 3.99, with Debt / Equity ratio of 16.43%

In the past 12 months, Alamar Biosciences, Inc. has paid 665.00K in taxes.

Alamar Biosciences, Inc. EV to EBITDA ratio is -59.26, with an EV/FCF ratio of -24.59.

Alamar Biosciences, Inc. has $250.05M in cash and marketable securities with $51.41M in debt, giving a net cash position of $198.65M billion.

Gross margin is 58.01%, with operating margin of -42.22%, and net profit margin of -40.18%.

The average price target for Alamar Biosciences, Inc. is $33.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy